A study for the effect of COVID-19 on childhood asthma
Not Applicable
- Conditions
- Diseases of the respiratory system
- Registration Number
- KCT0009040
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1. Among the pediatric asthma patients built in 2016-2018 who can be tracked
2. 11–23 years of age who have asthma symptoms (whirring, dyspnea, or chronic/repetitive cough) in the last 12 months and satisfy bronchodilator response = 12% (based on baseline FEV1 levels) or PC20 methacholine = 16 mg/mL or PD15 mannitol = 635 mg
Exclusion Criteria
1. Among the patients currently visiting the Department of Pediatrics at Asan Medical Center in Seoul, subjects aged 11-23 without childhood asthma or allergic diseases
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method bronchial potential for asthma
- Secondary Outcome Measures
Name Time Method pulmonary function